Series B

Aventura Private Wealth closes its second Anduril offering, signaling a major shift as private capital floods into high-tech defense disruptors.

With major grants from top foundations, Lario Therapeutics expands its precision neuroscience platform, offering new hope for complex neurological disorders.

AcuityMD's new Salesforce integration promises to eliminate data silos and boost sales for MedTech firms, marking a strategic leap for the AI unicorn.

With a sales backlog soaring to $7.1M, the clean tech firm is raising capital and realigning leadership to scale its innovative thermal energy systems.

A new platform powered by a 51%-returning AI firm aims to slash fund launch costs by 98%, potentially unleashing a new wave of financial entrepreneurs.

With new CEO John Slaven, MineSense aims to scale its ore-sorting tech globally, tackling the urgent need for sustainable critical mineral supplies.

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Tech titans like Micron, NVIDIA, and Applied Materials join forces in a $2.5B alliance to forge India into a global deep tech powerhouse.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

A new 68-unit affordable senior community in Castle Hayne is secured by a key federal loan, highlighting a successful model for rural housing needs.

From soil sensing to autonomous robots, see how five new startups are helping John Deere redefine the future of agriculture and construction.

With its first dedicated private credit fund, Brigade Capital is targeting a complex, underserved market segment to deliver what larger lenders often miss.

YBI's new 'Landing Zone' program offers a free, equity-free path for manufacturing startups, leveraging world-class expertise to enter the US market.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

With two high-profile board appointments, Stellaromics signals its ambition to dominate the 3D spatial omics market with its advanced Pyxa™ platform.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

iVeena promotes key execs as it prepares for clinical trials of a novel eye drop that could reshape pediatric myopia treatment worldwide.